Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder
2017 ◽
Vol 72
(2)
◽
pp. 64-72
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 6
(5)
◽
pp. 1604-1612
◽
Keyword(s):
2019 ◽
Vol 52
◽
pp. 596-602
◽
2017 ◽
Vol 31
(9)
◽
pp. 1190-1203
◽
2016 ◽
Vol Volume 12
◽
pp. 2859-2867
◽
Keyword(s):
2013 ◽
Vol 74
(07)
◽
pp. e636-e641
◽
2020 ◽
Vol 30
(6)
◽
pp. 355-365